When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

But using cells drawn from umbilical cord blood, Rezvani’s team have been able to manufacture around 40 million CD19-targeting chimeric natural killer cells in two weeks. She told the conference ...

For a source of NK cells, Rezvani turned to umbilical-cord blood. This source provides a large number of NK cells from healthy individuals, which work better than those from patients with cancer.